Mounjaro patient information: the facts, clearly explained

How does Mounjaro actually work in the body?

Most weight-management injections target a single gut hormone. Mounjaro is different: tirzepatide binds to both the GIP receptor and the GLP-1 receptor, the two main signalling pathways involved in appetite regulation and blood-sugar control. Activating both slows the rate at which food leaves the stomach, increases the sense of fullness after eating, and reduces how much you want to eat in the first place. The result, for most people, is that portion sizes fall naturally rather than through willpower.

GLP-1 receptor agonists have been used in type 2 diabetes care for over a decade, so the pathway is well understood. What makes tirzepatide novel is the addition of GIP signalling, which appears to enhance the appetite-reduction effect beyond what GLP-1 stimulation alone achieves. The NHS tirzepatide medicines page explains the mechanism in accessible terms and is worth bookmarking alongside your leaflet.

The injection is given once a week, under the skin of the abdomen, thigh, or upper arm. Rotating the site week to week reduces the chance of localised irritation. Storage matters too: pens need to be kept refrigerated at 2–8°C, and you should check the Mounjaro patient leaflet, which contains the precise window during which a pen kept at room temperature remains usable, as that window is finite and varies by product, so the leaflet is the authority, not a rough estimate from any website including this one. You can also download the Mounjaro patient information PDF to keep a copy to hand whenever you need to check dosing or storage details.

The dedicated Mounjaro information page on our site goes deeper on the science if you want more than the summary above.

Who is Mounjaro licensed to treat, and what does the prescriber assess?

The UK licence covers adults with a BMI of 30 or above, alongside a reduced-calorie diet and increased physical activity. Adults with a BMI of 27 to 29.9 also qualify if they have at least one weight-related health condition, for example, high blood pressure, high cholesterol, prediabetes, type 2 diabetes, or obstructive sleep apnoea. Ethnic-background adjustments apply: UK guidance sets the qualifying BMI threshold around 2.5 kg/m² lower for South Asian, Chinese, Middle Eastern, Black African, and African-Caribbean backgrounds.

BMI alone is not the whole picture. A prescriber considers your medical history, any medicines you take, and conditions that might affect safety. Mounjaro is not suitable for use during pregnancy, breastfeeding, or when trying to conceive, and it is not licensed for anyone under 18. A personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or previous pancreatitis requires careful discussion before any decision is made.

NICE recommends tirzepatide for NHS use in adults with a BMI of 35 or above plus at least one weight-related comorbidity, with the same ethnic-background adjustment, the detailed criteria are set out in NICE technology appraisal TA1026. Private routes through a regulated pharmacy carry the same eligibility principles from the licence but without the NHS's phased access restrictions. Either way, a qualified prescriber makes the call.

If you want to understand how the NHS rollout is unfolding versus what is available privately, the Mounjaro overview page covers both routes clearly.

What side effects should patients be prepared for?

The most common side effects are gastrointestinal. Nausea is the most frequently reported, particularly in the early weeks and after each dose increase; vomiting, diarrhoea, constipation, indigestion, and burping also occur. For most people, these settle within a couple of weeks as the body adjusts. Starting at 2.5 mg is specifically designed to give the body time to adapt before moving to a therapeutic dose, slow titration is the main tool for keeping side effects manageable.

Fatigue, headache, dizziness, and injection-site reactions (redness, itching, mild swelling) are also documented. These are generally mild and short-lived.

Two side effects deserve particular attention. Acute pancreatitis is rare but serious: if you develop severe, persistent stomach pain that radiates to your back, with or without vomiting, seek urgent medical help and tell the clinician you are taking tirzepatide. The MHRA highlighted this in a formal Drug Safety Update in January 2026 covering GLP-1 medicines. Gallbladder problems have also been reported with this class of medicine; symptoms such as persistent upper-right abdominal pain or jaundice should prompt a same-day call to your GP or 111.

Patients and carers can report any suspected side effect directly through the MHRA Yellow Card scheme, this is how post-market safety data is gathered, and reports from real patients are genuinely useful to regulators.

If you are prescribed Mounjaro through nume and something concerns you between doses, our aftercare team is available seven days a week. Details are on the contact page.

How is Mounjaro prescribed and dispensed in the UK?

Mounjaro is a prescription-only medicine. That single fact shapes everything about how it can legally be obtained. A prescriber must assess your eligibility and authorise a prescription; without that clinical step, supply is not lawful, and in practice it is dangerous, because counterfeit pens have been seized in significant quantities across the UK, some containing insulin rather than tirzepatide.

When verifying any online pharmacy, the GPhC register is the place to start. You can search by name or registration number at pharmacyregulation.org/registers. At nume, our GPhC premises registration is 9012878. Our prescribers personally review every consultation the same day it is submitted; there is no automated decision-making.

A practical note on timing: if you are planning a first order around a bank holiday or the end of the month, it is worth submitting your consultation a day or two early. Orders placed by 12pm on a working day, once clinically approved, are dispatched the same day by DPD for next-working-day delivery. Holidays shift that by a day. It is worth building that margin in.

For a fuller look at what the consultation involves and what happens step by step, the guide to getting Mounjaro through nume covers the process in detail. If you are ready to check whether you meet the criteria, the free consultation is the place to start. There is no charge for the consultation or the prescription, one transparent price covers everything, and there is no subscription.

Cost is a reasonable question. A realistic sense of what private treatment runs, and why prices vary between providers, is set out on the weight-loss treatments overview.